E-LIB Suche - Ergebnisse für: Ware, Joseph A.

1

Evaluation of the Pharmacokinetics and Safety of a Single D..:

Xu, Yan ; Izumi, Raquel ; Nguyen, Helen...
The Journal of Clinical Pharmacology. 62 (2022) 6 - p. 812-822 , 2022

Link: https://doi.org/10.1002/..

2

Acalabrutinib CYP3A‐mediated drug–drug interactions: Clinic..:

Chen, Buyun ; Zhou, Diansong ; Wei, Hua...
British Journal of Clinical Pharmacology. 88 (2022) 8 - p. 3716-3729 , 2022

Link: https://doi.org/10.1111/..

3

Bioavailability of acalabrutinib suspension delivered via n..:

Sharma, Shringi ; Pepin, Xavier ; Cheung, Jean...
British Journal of Clinical Pharmacology. 88 (2022) 10 - p. 4573-4584 , 2022

Link: https://doi.org/10.1111/..

4

Bioequivalence and Relative Bioavailability Studies to Asse..:

Sharma, Shringi ; Pepin, Xavier ; Burri, Harini...
Clinical Pharmacology in Drug Development. 11 (2022) 11 - p. 1294-1307 , 2022

Link: https://doi.org/10.1002/..

5

Improved characterization of the pharmacokinetics of acalab..:

Edlund, Helena ; Bellanti, Francesco ; Liu, Huan...
British Journal of Clinical Pharmacology. 88 (2021) 2 - p. 846-852 , 2021

Link: https://doi.org/10.1111/..

6

Mechanistic physiology-based pharmacokinetic modeling to el..:

Pilla Reddy, Venkatesh ; Fretland, Adrian J. ; Zhou, Diansong...
Cancer Chemotherapy and Pharmacology. 88 (2021) 3 - p. 451-464 , 2021

Link: https://doi.org/10.1007/..

7

Exposure–response analysis of acalabrutinib and its active ..:

Edlund, Helena ; Buil‐Bruna, Núria ; Vishwanathan, Karthick...
British Journal of Clinical Pharmacology. 88 (2021) 5 - p. 2284-2296 , 2021

Link: https://doi.org/10.1111/..

8

Quantitative systems pharmacology model‐based investigation..:

Gadkar, Kapil ; Friedrich, Christina ; Hurez, Vincent...
CPT: Pharmacometrics & Systems Pharmacology. 11 (2021) 5 - p. 616-627 , 2021

Link: https://doi.org/10.1002/..

9

Intrinsic and Extrinsic Pharmacokinetic Variability of Smal..:

Reyner, Eric ; Lum, Bert ; Jing, Jing...
Clinical and Translational Science. 13 (2019) 2 - p. 410-418 , 2019

Link: https://doi.org/10.1111/..

10

Investigation of the absolute bioavailability and human mas..:

Ma, Shuguang ; Suchomel, Julia ; Yanez, Evelyn...
British Journal of Clinical Pharmacology. 85 (2019) 8 - p. 1751-1760 , 2019

Link: https://doi.org/10.1111/..

11

Evaluation of the Drug–Drug Interaction Potential of Acalab..:

Zhou, Diansong ; Podoll, Terry ; Xu, Yan...
CPT: Pharmacometrics & Systems Pharmacology. 8 (2019) 7 - p. 489-499 , 2019

Link: https://doi.org/10.1002/..

12

Effect of OATP1B1/1B3 Inhibitor GDC‐0810 on the Pharmacokin..:

Liu, Lichuan ; Cheeti, Sravanthi ; Yoshida, Kenta...
The Journal of Clinical Pharmacology. 58 (2018) 11 - p. 1427-1435 , 2018

Link: https://doi.org/10.1002/..

13

Disease‐Associated Changes in Drug Transporters May Impact ..:

Evers, Raymond ; Piquette‐Miller, Micheline ; Polli, Joseph W....
Clinical Pharmacology & Therapeutics. 104 (2018) 5 - p. 900-915 , 2018

Link: https://doi.org/10.1002/..

14

ITC Commentary on Metformin Clinical Drug–Drug Interaction ..:

Zamek‐Gliszczynski, Maciej J. ; Chu, Xiaoyan ; Cook, Jack A....
Clinical Pharmacology & Therapeutics. 104 (2018) 5 - p. 781-784 , 2018

Link: https://doi.org/10.1002/..

15

Absorption, metabolism, and excretion of taselisib (GDC-003..:

Ma, Shuguang ; Salphati, Laurent ; Srikumar, Srikumar...
Drug Metabolism and Pharmacokinetics. 32 (2017) 1 - p. S74-S75 , 2017

Link: https://doi.org/10.1016/..